Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2006-08-25
2009-12-01
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
Reexamination Certificate
active
07625724
ABSTRACT:
The present invention includes compositions and methods for the identification, characterization and use of a novel anti-viral protein that includes a mitochondrial anti-viral signaling protein.
REFERENCES:
patent: 2006/0275794 (2006-12-01), Carrino et al.
patent: WO 2007/013391 (2007-02-01), None
Crozat, K., and Beutler, B. (2004). TLR7: A new sensor of viral infection. Proc Natl Acad Sci U S A 101, 6835-6836.
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., and Reis e Sousa, C. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531.
Freundt, E. C., and Lenardo, M. J. (2005). Interfering with interferons: Hepatitis C virus counters innate immunity. Proc Natl Acad Sci U S A 102, 17539-17540.
Hiscott, J., Grandvaux, N., Sharma, S., Tenoever, B. R., Servant, M. J., and Lin, R. (2003). Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann N Y Acad Sci 1010, 237-248.
Kaufmann, T., Schlipf, S., Sanz, J., Neubert, K., Stein, R., and Borner, C. (2003). Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol 160, 53-64.
Kovacsovics, M., Martinon, F., Micheau, O., Bodmer, J. L., Hofmann, K., and Tschopp, J. (2002). Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation. Curr Biol 12, 838-843.
Li, X. D., Sun, L., Seth, R. B., Pineda, G., and Chen, Z. J. (2005). Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102, 17717-17722.
McWhirter, S. M., Tenoever, B. R., and Maniatis, T. (2005). Connecting mitochondria and innate immunity. Cell 122, 645-647.
Schwer, B., Ren, S., Pietschmann, T., Kartenbeck, J., Kaehlcke, K., Bartenschlager, R., Yen, T. S., and Ott, M. (2004). Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol 78, 7958-7968.
Seth, R. B., Sun, L., Ea, C. K., and Chen, Z. J. (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-682.
Xu. L G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z., and Shu, H. B. (2005). VISA Is an Adapter Protein Required for Virus-Triggered IFN-beta Signaling. Mol Cell 19, 727-740.
Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., et al. (2002). Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447.
Bhargava Rashu Seth
Chen Zhijian James
Li Xiao-Dong
Sun Lijun
Board of Regents , The University of Texas System
Chalker Flores LLP
Flores Edwin S.
Salimi Ali R.
Singleton Chainey P.
LandOfFree
MAVS in the prevention and treatment of viral diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with MAVS in the prevention and treatment of viral diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MAVS in the prevention and treatment of viral diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4127793